Supply agreement with major US customer
Filed with ASX · · 2 pages · English
• Genetic Signatures secures new North American customer for its EasyScreen SARS-CoV-2 Detection Kit • The two-year supply agreement is for reagents to meet demand for estimated 1,000 tests per day • First order received, to be invoiced in December • Warehouse facility established in Los Angeles, California to support customer supply across North America Genetic Signatures Limited (ASX: GSS, “Gene
Genetic Signatures Ltd. on 6ix
Earlier from Genetic Signatures
- First quarter sales update
- Preliminary Final Report
- Quarterly report and Appendix 4C
- S&P DJI Announces June 2020 Quarterly Rebalance
- Appendix 4C & quarterly update
Later from Genetic Signatures
- CE-IVD received for STI test
- Investor update
- 3base SARS-CoV-2 kit registered by TGA for saliva samples
- S&P DJI Announces March 2022 Quarterly Rebalance
- Public Health Wales Awards Enteric Testing Contract to GSS
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures